Search Results (39)
Click the Why column to see why an item matched the search.
| Match | Type | Why |
|---|
| Pharmacovigilance | Concept |
Why?
|
| Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study. | Academic Article |
Why?
|
| Ivermectin associated adverse events in the treatment and prevention of COVID-19 reported to the FACT pharmacovigilance project. | Academic Article |
Why?
|
| Identification of Bradycardia Following Remdesivir Administration Through the US Food and Drug Administration American College of Medical Toxicology COVID-19 Toxic Pharmacovigilance Project. | Academic Article |
Why?
|
| Kao, David | Person |
Why?
|
| Reduced risk of suicidal behaviours associated with the treatment of hidradenitis suppurativa with tumour necrosis factor alpha antagonists: results from the US FDA Adverse Events Reporting System pharmacovigilance database. | Academic Article |
Why?
|
| Adverse event reporting in patients treated with levothyroxine: results of the pharmacovigilance task force survey of the american thyroid association, american association of clinical endocrinologists, and the endocrine society. | Academic Article |
Why?
|
| Clinically Inconsequential Alerts: The Characteristics of Opioid Drug Alerts and Their Utility in Preventing Adverse Drug Events in the Emergency Department. | Academic Article |
Why?
|
| Adverse drug event rates in pediatric pulmonary hypertension: a comparison of real-world data sources. | Academic Article |
Why?
|
| Development of a Safety Surveillance Plan for the Academic Medicine Sponsor Performing First-in-Human Cellular Therapy Clinical Trials: A Report from the Consortium for Pediatric Cellular Immunotherapy. | Academic Article |
Why?
|
| From Patient Registry to Multi-Center Research Consortium: the Toxicology Investigators Consortium (ToxIC) Turns Fifteen. | Academic Article |
Why?
|
| Variation of the prevalence of pediatric polypharmacy: A scoping review. | Academic Article |
Why?
|
| Enhancing Medication Safety in Children with Polypharmacy Using Parent-Reported Symptom Assessments | Grant |
Why?
|
| Regensteiner, Judith | Person |
Why?
|
| Autoimmune hepatitis: Brighton Collaboration case definition and guidelines for data collection, analysis, and presentation of immunisation safety data. | Academic Article |
Why?
|